Skip to main content

Advertisement

Table 1 Summary of patient characteristics

From: Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults

Characteristics N = 61
Age 18 (<1–65)*
Children ( <18 y ) 29
Sex ( M/F ) 38/23
Diagnosis:  
Non-malignant 13
Acute myeloid leukemia/Acute lymphoid leukemia 12/13
Chronic lymphoid leukemia 4
Myelodysplastic syndrome 11
Other malignancies 8
Stage ( early/late ) 16/32
Donor age 26 (0–62)
Donor sex ( M/F ) 38/23
Donor  
Sibling/HLA-identical, related 21
MUD 32
HLA-mismatched, unrelated 8
Conditioning  
MAC/RIC 34/27
Chemo-based 38
TBI-based 23
ATG 47 (77%)
GVHD prophylaxis  
CsA ± MTX 41
CsA + Prednisolon 3
Tacrolimus + Sirolimus 16
CsA + MTX + Cy 1
Stem cell source:  
BM/PBSCs/CB 25/31/5
  1. *Median [4].
  2. Abbreviations: MUD matched unrelated donor, MAC myeloablative conditioning, RICreduced-intensity conditioning, TBI total body irradiation, ATG anti-thymocyte globulin, GVHD graft-versus-host disease, CsA cyclosporine, MTX methotrexate, Cy cyclophosphamide, BM bone marrow, PBSCs peripheral blood stem cells, CB cord blood.